참고문헌
- Abdel-Aziz F, Habib M, Mohamed MK, et al (2000). Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology, 32, 111-5. https://doi.org/10.1053/jhep.2000.8438
- Altekruse S, McGlynn K Reichman M (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol, 27,1485-91. https://doi.org/10.1200/JCO.2008.20.7753
- Attallah AM, El-Far M, Abdel Malak C, et al (2011). Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma. Clinica Chimica Acta, 412, 2310-5. https://doi.org/10.1016/j.cca.2011.08.029
- Bessa S, Elwan N, Suliman G, El-Shourbagy S (2010). Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma. Arch Med Res, 41, 541-7. https://doi.org/10.1016/j.arcmed.2010.10.007
- Bruix J and Sherman M (2005). Management of hepatocellular carcinoma. Hepatology, 42, 1208-36. https://doi.org/10.1002/hep.20933
- Critchley DR, Talin In Kreis T, Vale R (1999). Guidebook to the extracellular matrix, anchor, and adhesion proteins. Oxford University Press, pp. 82-85, Oxford.
- El-Serag HB (2004). Hepatocellular carcinoma: recent trends in the United States. Gastroenterology, 127, 27-34. https://doi.org/10.1053/j.gastro.2004.09.013
- El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76. https://doi.org/10.1053/j.gastro.2007.04.061
- El-Zayadi AR, Badran HM, Barakat EM, et al (2005). Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol, 11, 5193-8.
- Ferlay J, Bray F, Pisani P (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Press; Lyon: 2004. IARC CancerBase No. 5. version 2.0.
- Freedman L, Edwards B, Ries L (2006). Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the middle east cancer consortium (MECC) compared with US SEER. National Cancer Institute. Bethesda, MD: NIH Pub. No. 06-5873.
- Hassan MM, Zaghloul AS, El-Serag HB (2001). The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol, 33, 123-6. https://doi.org/10.1097/00004836-200108000-00006
- Horwitz A, Duggan K, Buck C, et al (1986). Interaction of plasma-membrane fibronectin receptor with talin - a transmembrane linkage. Nature, 320, 531-3. https://doi.org/10.1038/320531a0
- Kanamori H, Kawakami T, Effendi K, et al (2011). Identification by differential tissue proteome analysis of Talin-1 as a novel molecular marker of progression of hepatocellular carcinoma. Oncology, 80, 406-15. https://doi.org/10.1159/000330734
- Khattab MA, Eslam M, Sharwae MA (2010). Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control, 38, 640-1. https://doi.org/10.1016/j.ajic.2009.12.016
- Liotta LA, Kohn E (2004). Anoikis: cancer and the homeless cell. Nature, 430, 973-4. https://doi.org/10.1038/430973a
- Makuuchi M, Kokudo N, Arii S, et al (2008). Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res, 38, 37-51. https://doi.org/10.1111/j.1872-034X.2007.00216.x
- Mendy M, Walton R (2009). Molecular pathogenesis and early detection of hepatocellular carcinoma-perspectives from West Africa. Cancer Lett, 286, 44-51. https://doi.org/10.1016/j.canlet.2009.04.039
- Mizejewski GJ (1999). Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med, 222, 124-38. https://doi.org/10.1046/j.1525-1373.1999.d01-122.x
- Parkin D, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
- Parkin D, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Sakamoto S, McCann RO, Dhir R, Kyprianou N (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res, 70, 1885-95. https://doi.org/10.1158/0008-5472.CAN-09-2833
- Senetar M, Moncman C, McCann R (2007). Talin2 is induced during striated muscle differentiation and istargeted to stable adhesion complexes in mature muscle. Cell Motil Cytoskeleton, 64, 157-73. https://doi.org/10.1002/cm.20173
- Senetar MA, McCann RO (2005). Gene duplication and functional divergence during evolution of the cytoskeletal linker protein talin. Gene, 362, 141-52. https://doi.org/10.1016/j.gene.2005.08.012
- Slater M, Cooper M, Murphy CR (2007). The cytoskeletal proteins alpha-actinin, Ezrin, and talin are De-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Appl Immunohistochem Mol Morphol, 15, 170-4. https://doi.org/10.1097/01.pai.0000194762.78889.26
- Tadokoro S, Shattil SJ, Eto K, et al (2003). Talin binding to integrin beta tails:a final common step in integrin activation. Science, 302, 103-6. https://doi.org/10.1126/science.1086652
- Teofanescu I, Gologan E, Stefanescu E, Balan G (2010). Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis. Rev Med Chir Soc Med Nat Iasi, 114, 39-46.
- Thomas M, Zhu A (2005). Hepatocellular carcinoma: the need for progress. J Clin Oncol, 23, 2892-9. https://doi.org/10.1200/JCO.2005.03.196
- Tsujioka M, Yoshida K, Inouye K (2004). Talin B is required for force transmission in morphogenesis of dictyostelium. EMBO J, 23, 2216-25. https://doi.org/10.1038/sj.emboj.7600238
- Zhang JL, Qian YB, Zhu LX, Xiong QR (2011). Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas. Asian Pac J Cancer Prev, 12, 3265-9.
- Zhang X, Jiang G, Cai Y, et al (2008). Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol, 10, 1062-8. https://doi.org/10.1038/ncb1765
피인용 문헌
- Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma Cells vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2655
- Hepatoprotective Effects of Curcumin Against Diethyl Nitrosamine Induced Hepatotoxicity in Albino Rats vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.103
- Plasma Nuclear Factor Kappa B and Serum Peroxiredoxin 3 in Early Diagnosis of Hepatocellular Carcinoma vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1657
- Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2076-9
- Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review) vol.36, pp.2, 2016, https://doi.org/10.3892/or.2016.4842
- TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein vol.6, pp.5, 2017, https://doi.org/10.1038/oncsis.2017.39
- Effect of talin1 on apoptosis in hepatoma carcinoma cells via the PI3K/Akt/NF-κB signaling pathway vol.7, pp.64, 2017, https://doi.org/10.1039/C7RA05792J
- Serological tumor markers of hepatocellular carcinoma: a meta-analysis vol.30, pp.1, 2015, https://doi.org/10.5301/jbm.5000119